ArticleApplied biochemistry and biotechnology2025
Enhanced Tetracycline Degradation by Laccase Immobilized on Carboxymethyl Starch Magnetic Nanoparticles: Optimization of Degradation Conditions, Reusability, and Degradation Pathways.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Alkali-treated Phragmites karka as a sustainable support for immobilized Anoxybacteroides rupiense UE27 in laccase production and azo dye detoxification.World journal of microbiology & biotechnology · 2026Article
- Synergistic Degradation of Parabens via Laccase/TEMPO/Cutinase System: Performance and Mechanism.Applied biochemistry and biotechnology · 2026Article
- Enhanced Catalytic Performance and Stability of Sucrose Isomerase Via CuApplied biochemistry and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bioremediation using laccase (Lac) to degrade tetracycline (TC) contaminant is promising due to high specificity and selectivity of the biocatalyst. However, degradation parameters should be carefully studied to achieve maximum degradation efficiency. Thus, the current study aimed to degrade TC by employing Lac immobilized on novel carboxymethyl starch magnetic nanoparticles (CMS-MNP). The maximum TC degradation was determined via one-factor-at-a-time (OFAT) and central composite design (CCD). Using OFAT, the maximum TC degradation (56.3%) was achieved at initial TC concentration of 20 mg/mL, pH 6, 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) concentration of 1.2 mM, and 10 h of reaction time. When CCD was employed, the TC degradation increased by one-fold with the highest TC degradation (62.1%) recorded at initial TC concentration of 25 mg/L, pH 5.7, ABTS concentration of 1.0 mM, and 11.8 h of reaction time. The CMS-MNP-Lac was reused for 7 cycles with a total TC degradation of 73 mg/L. The TC degradation in this study demonstrated outstanding potential and provided a green alternative for the treatment of TC contaminants in the environment.
Indexed as
Identifiers
40397296What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.